Wikidata

(Q84210080)

English

Niacin extended-release therapy in phase III clinical trials is associated with relatively low rates of drug discontinuation due to flushing and treatment-related adverse events: a pooled analysis

scientific article published on 01 June 2011

In more languages

Statements

title
Niacin extended-release therapy in phase III clinical trials is associated with relatively low rates of drug discontinuation due to flushing and treatment-related adverse events: a pooled analysis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21619381
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21619381%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q84210080&oldid=1533674027"